Aoxin Q&M acquires 49% stake in Q&M's Acumen for $29.4 mil

Atiqah Mokhtar
Atiqah Mokhtar10/4/2021 7:53 AM GMT+08  • 2 min read
Aoxin Q&M acquires 49% stake in Q&M's Acumen for $29.4 mil
Q&M, which owns a 32.95% stake in Aoxin Q&M, will have effective ownership of 67.15% in Acumen post-transaction.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Catalist-listed Aoxin Q&M Dental Group will acquire 49% interest in medical diagnostics company Acumen Diagnostics for $29.4 mil, according to a joint announcement by the company and Mainboard-listed Q&M Dental Group.

Acumen is a subsidiary of Q&M, which holds a 51% stake in the company.

Aoxin is acquiring the stake in Acumen from its shareholders Acumen Holdings and Dr Ong Siew Hwa, Acumen's CEO and chief scientist. Upon completion of the transaction, Aoxin will hold 49% of Acumen Diagnostics, while Q&M will retain the remaining 51%.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.